188 related articles for article (PubMed ID: 18337650)
1. S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients.
Faye RS; Paus E; Maelandsmo GM; Berner A; Høifødt HK; Fodstad Ø; Aamdal S
Melanoma Res; 2008 Apr; 18(2):134-40. PubMed ID: 18337650
[TBL] [Abstract][Full Text] [Related]
2. [Serum S100B protein and stage of cutaneous melanoma: a prospective study].
Brouard M; Quillien V; Ollivier I; Lesimple T; Adamski H; Chevrant-Breton J
Ann Dermatol Venereol; 2000 Jan; 127(1):56-9. PubMed ID: 10717564
[TBL] [Abstract][Full Text] [Related]
3. S100B protein in benzodiazepine overdose.
Ambrozic J; Bunc M; Osredkar J; Brvar M
Emerg Med J; 2008 Feb; 25(2):90-2. PubMed ID: 18212144
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma.
Garnier JP; Letellier S; Cassinat B; Lebbé C; Kerob D; Baccard M; Morel P; Basset-Seguin N; Dubertret L; Bousquet B; Stoitchkov K; Le Bricon T
Eur J Cancer; 2007 Mar; 43(4):816-21. PubMed ID: 17276671
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.
Egberts F; Pollex A; Egberts JH; Kaehler KC; Weichenthal M; Hauschild A
Onkologie; 2008 Jul; 31(7):380-4. PubMed ID: 18596385
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of serum S100B protein in critically ill patients without brain injury.
Routsi C; Stamataki E; Nanas S; Psachoulia C; Stathopoulos A; Koroneos A; Zervou M; Jullien G; Roussos C
Shock; 2006 Jul; 26(1):20-4. PubMed ID: 16783193
[TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
[TBL] [Abstract][Full Text] [Related]
8. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients.
Faries MB; Gupta RK; Ye X; Lee C; Yee R; Leopoldo Z; Essner R; Foshag LJ; Elashoff D; Morton DL
Cancer Invest; 2007 Aug; 25(5):285-93. PubMed ID: 17661202
[TBL] [Abstract][Full Text] [Related]
11. Evening and morning plasma levels of protein S100B in patients with obstructive sleep apnea.
Sonka K; Kelemen J; Kemlink D; Volná J; Pretl M; Zima T; Benakova H; Rambousek P; Foltán R; Donev F
Neuro Endocrinol Lett; 2007 Oct; 28(5):575-9. PubMed ID: 17984939
[TBL] [Abstract][Full Text] [Related]
12. [Clinical values of detection of serum levels of S100B and NSE in diagnosis of brain injuries at early period after cardiopulmonary bypass].
Gu XH; Zhang G; Zhang XQ; Song Y; Wang T; Li SX
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):975-7. PubMed ID: 17650423
[TBL] [Abstract][Full Text] [Related]
13. S100B protein in conscious carbon monoxide-poisoned rats treated with normobaric or hyperbaric oxygen.
Brvar M; Finderle Z; Suput D; Bunc M
Crit Care Med; 2006 Aug; 34(8):2228-30. PubMed ID: 16763504
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.
Nylén K; Ost M; Csajbok LZ; Nilsson I; Hall C; Blennow K; Nellgård B; Rosengren L
Acta Neurochir (Wien); 2008 Mar; 150(3):221-7; discussion 227. PubMed ID: 18193148
[TBL] [Abstract][Full Text] [Related]
15. Effects of mode of delivery on maternal-neonatal plasma antioxidant status and on protein S100B serum concentrations.
Schulpis KH; Margeli A; Akalestos A; Vlachos GD; Partsinevelos GA; Papastamataki M; Antsaklis A; Papassotiriou I
Scand J Clin Lab Invest; 2006; 66(8):733-42. PubMed ID: 17101566
[TBL] [Abstract][Full Text] [Related]
16. Serum markers in skin melanoma--preliminary study.
Dumitraşcu G; Constantin C; Manda G; Hristescu S; Mărgaritescu I; Chiriţă D; Neagu M
Roum Arch Microbiol Immunol; 2009; 68(3):125-35. PubMed ID: 20361532
[TBL] [Abstract][Full Text] [Related]
17. Serum S100B levels in patients with neural tube defects.
Netto CB; Portela LV; Félix TM; Souza DO; Gonçalves CA; Giugliani R
Clin Chim Acta; 2006 Feb; 364(1-2):275-8. PubMed ID: 16143320
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
19. Serum S100B levels in patients after cardiac surgery: possible sources of contamination.
Babin-Ebell J; Roth P; Reese J; Bechtel M; Mortasawi A
Thorac Cardiovasc Surg; 2007 Apr; 55(3):168-72. PubMed ID: 17410502
[TBL] [Abstract][Full Text] [Related]
20. Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B.
Stoitchkov K; Letellier S; Garnier JP; Bousquet B; Tsankov N; Morel P; Ghanem G; Le Bricon T
Melanoma Res; 2002 Jun; 12(3):255-62. PubMed ID: 12140382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
